{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:26:51Z","timestamp":1792553211738,"version":"4.5.0"},"reference-count":95,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016293","name":"Elsie & Marvin Dekelboum Family Foundation Rockville Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016293","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001698","name":"Israel Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001698","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020513","name":"Ministero della transizione ecologica","doi-asserted-by":"publisher","award":["101123436"],"award-info":[{"award-number":["101123436"]}],"id":[{"id":"10.13039\/100020513","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006221","name":"United States - Israel Binational Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006221","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008273","name":"Novartis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008273","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["ABA-25-1373817"],"award-info":[{"award-number":["ABA-25-1373817"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014599","name":"Mark Foundation For Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014866","name":"Herberger Institute for Design and the Arts","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014866","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012273","name":"Lotte and John Hecht Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012273","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["259373024"],"award-info":[{"award-number":["259373024"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["1944\/22"],"award-info":[{"award-number":["1944\/22"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001735","name":"Weizmann Institute of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"H2020 European Research Council","doi-asserted-by":"publisher","award":["101055341-TROJAN-Cell"],"award-info":[{"award-number":["101055341-TROJAN-Cell"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001738","name":"Ministry of Innovation, Science and Technology","doi-asserted-by":"publisher","award":["1001703362"],"award-info":[{"award-number":["1001703362"]}],"id":[{"id":"10.13039\/501100001738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ccell.2025.11.009","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T15:39:03Z","timestamp":1769096343000},"page":"519-533.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Tumor-antigen-independent targeting of solid tumors by armored macrophage-directed anti-TREM2 CAR T cells"],"prefix":"10.1016","volume":"44","author":[{"given":"Gal","family":"Yagel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Rimini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"von Locquenghien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Avellino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oren","family":"Barboy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Chalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaya","family":"Granot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shir","family":"Shlomi-Loubaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi","family":"Sheban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kfir","family":"Mazuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyal","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Zwicky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3021-6799","authenticated-orcid":false,"given":"Ido","family":"Amit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccell.2025.11.009_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-021-00459-7","article-title":"CAR-T cell therapy: current limitations and potential strategies","volume":"11","author":"Sterner","year":"2021","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.ccell.2025.11.009_bib2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13287-020-02128-1","article-title":"CAR T cells in solid tumors: challenges and opportunities","volume":"12","author":"Marofi","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.ccell.2025.11.009_bib3","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1158\/2159-8290.CD-21-0407","article-title":"A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti\u2013PD-1 agent pembrolizumab","volume":"11","author":"Adusumilli","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2025.11.009_bib4","doi-asserted-by":"crossref","first-page":"6276","DOI":"10.1038\/s41598-021-85747-9","article-title":"Anti-mucin 1 chimeric antigen receptor T cells for adoptive T cell therapy of cholangiocarcinoma","volume":"11","author":"Supimon","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ccell.2025.11.009_bib5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41435-024-00275-6","article-title":"HER2-targeting CAR-T cells show highly efficient anti-tumor activity against glioblastoma both in vitro and in vivo","volume":"25","author":"Li","year":"2024","journal-title":"Gene Immun."},{"key":"10.1016\/j.ccell.2025.11.009_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.669071","article-title":"Case report: prolonged survival following EGFRvIII CAR T cell treatment for recurrent glioblastoma","volume":"11","author":"Durgin","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ccell.2025.11.009_bib7","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.ymthe.2017.03.010","article-title":"Phase I escalating-dose trial of CAR-T therapy targeting CEA+ metastatic colorectal cancers","volume":"25","author":"Zhang","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ccell.2025.11.009_bib8","article-title":"GPC3-targeted CAR-T cells secreting B7H3-targeted BiTE exhibit potent cytotoxicity activity against hepatocellular carcinoma cell in the in vitro assay","volume":"31","author":"Cao","year":"2022","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.ccell.2025.11.009_bib9","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/s41591-022-01800-8","article-title":"Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results","volume":"28","author":"Qi","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2025.11.009_bib10","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/s41591-024-03451-3","article-title":"Intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trial","volume":"31","author":"Vitanza","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2025.11.009_bib11","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41591-022-01726-1","article-title":"PSMA-targeting TGF\u03b2-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial","volume":"28","author":"Narayan","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2025.11.009_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ymthe.2017.10.002","article-title":"Optimization of IL13R\u03b12-targeted chimeric antigen receptor T cells for improved anti-tumor efficacy against glioblastoma","volume":"26","author":"Brown","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ccell.2025.11.009_bib13","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1007\/s00262-023-03423-5","article-title":"IL13R\u03b12-targeted third-generation CAR-T cells with CD28 transmembrane domain mediate the best anti-glioblastoma efficacy","volume":"72","author":"Gu","year":"2023","journal-title":"Cancer Immun. Immunother."},{"key":"10.1016\/j.ccell.2025.11.009_bib14","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJMoa2210859","article-title":"GD2-CART01 for relapsed or refractory high-risk neuroblastoma","volume":"388","author":"Del Bufalo","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ccell.2025.11.009_bib15","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1440169","article-title":"CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial","volume":"7","author":"Wang","year":"2018","journal-title":"OncoImmunology"},{"key":"10.1016\/j.ccell.2025.11.009_bib16","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1846926","article-title":"Efficacy and biomarker analysis of CD133-directed CAR T cells in advanced hepatocellular carcinoma: a single-arm, open-label, phase II trial","volume":"9","author":"Dai","year":"2020","journal-title":"OncoImmunology"},{"key":"10.1016\/j.ccell.2025.11.009_bib17","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/mt.2013.17","article-title":"Treatment of Metastatic Renal Cell Carcinoma With CAIX CAR-engineered T cells: Clinical Evaluation and Management of On-target Toxicity","volume":"21","author":"Lamers","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ccell.2025.11.009_bib18","article-title":"Bright future or blind alley? CAR-T cell therapy for solid tumors","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ccell.2025.11.009_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1113882","article-title":"The current landscape of CAR T-cell therapy for solid tumors: Mechanisms, research progress, challenges, and counterstrategies","volume":"14","author":"Daei Sorkhabi","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ccell.2025.11.009_bib20","article-title":"CAR-T-cell products in solid tumors: Progress, challenges, and strategies","volume":"2","author":"Qian","year":"2024","journal-title":"Interdiscip. Med."},{"key":"10.1016\/j.ccell.2025.11.009_bib21","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.trecan.2024.01.003","article-title":"Targeting solid tumor antigens with chimeric receptors: cancer biology meets synthetic immunology","volume":"10","author":"Kembuan","year":"2024","journal-title":"Trends Cancer"},{"key":"10.1016\/j.ccell.2025.11.009_bib22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.omto.2022.03.009","article-title":"CAR T cell therapy and the tumor microenvironment: Current challenges and opportunities","volume":"25","author":"Kankeu Fonkoua","year":"2022","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.ccell.2025.11.009_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/2326-6066.CIR-16-0297","article-title":"Myeloid-Derived Suppressor Cells","volume":"5","author":"Gabrilovich","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ccell.2025.11.009_bib24","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3390\/pharmaceutics16070865","article-title":"Immunotherapies Targeting Tumor-Associated Macrophages (TAMs) in Cancer","volume":"16","author":"Li","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ccell.2025.11.009_bib25","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1016\/j.cell.2025.10.030","article-title":"Macrophage-targeted immunocytokine leverages myeloid, T, and NK cell synergy for cancer immunotherapy","volume":"188","author":"von Locquenghien","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.11.009_bib26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cell.2023.11.032","article-title":"Time-resolved single-cell transcriptomics defines immune trajectories in glioblastoma","volume":"187","author":"Kirschenbaum","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.11.009_bib27","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1158\/2159-8290.CD-23-0299","article-title":"Spatial and temporal mapping of breast cancer lung metastases identify TREM2 macrophages as regulators of the metastatic boundary","volume":"13","author":"Yofe","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2025.11.009_bib28","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/s41590-023-01475-4","article-title":"TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer","volume":"24","author":"Park","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ccell.2025.11.009_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109844","article-title":"Targeting TREM2 on tumor-associated macrophages enhances immunotherapy","volume":"37","author":"Binnewies","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.ccell.2025.11.009_bib30","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.cell.2020.07.013","article-title":"TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy","volume":"182","author":"Molgora","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.11.009_bib31","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1158\/2326-6066.CIR-21-1075","article-title":"Targeting Macrophages with CAR T Cells Delays Solid Tumor Progression and Enhances Antitumor Immunity","volume":"10","author":"S\u00e1nchez-Paulete","year":"2022","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ccell.2025.11.009_bib32","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/s41467-021-20893-2","article-title":"CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy","volume":"12","author":"Rodriguez-Garcia","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2025.11.009_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-10940-8","article-title":"Armored CAR T cells enhance antitumor efficacy and overcome the tumor microenvironment","volume":"7","author":"Yeku","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ccell.2025.11.009_bib34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41551-021-00831-9","article-title":"Intratumourally injected alum-tethered cytokines elicit potent and safer local and systemic anticancer immunity","volume":"6","author":"Agarwal","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ccell.2025.11.009_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167159","article-title":"Armed with IL-2 based fusion protein improves CAR-T cell fitness and efficacy against solid tumors","volume":"1870","author":"Li","year":"2024","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"key":"10.1016\/j.ccell.2025.11.009_bib36","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1158\/1078-0432.CCR-14-2085","article-title":"Tumor-infiltrating lymphocytes genetically engineered with an inducible gene encoding interleukin-12 for the immunotherapy of metastatic melanoma","volume":"21","author":"Zhang","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2025.11.009_bib37","doi-asserted-by":"crossref","first-page":"e994446","DOI":"10.4161\/2162402X.2014.994446","article-title":"IL-12 secreting tumor-targeted chimeric antigen receptor T cells eradicate ovarian tumors in vivo","volume":"4","author":"Koneru","year":"2015","journal-title":"OncoImmunology"},{"key":"10.1016\/j.ccell.2025.11.009_bib38","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1158\/2326-6066.CIR-16-0376","article-title":"Transgenic expression of IL15 improves antiglioma activity of IL13R\u03b12-CAR T cells but results in antigen loss variants","volume":"5","author":"Krenciute","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ccell.2025.11.009_bib39","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/s41587-019-0398-2","article-title":"Interleukin-23 engineering improves CAR T cell function in solid tumors","volume":"38","author":"Ma","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ccell.2025.11.009_bib40","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jcyt.2020.08.005","article-title":"Inducible secretion of IL-21 augments anti-tumor activity of piggyBac-manufactured chimeric antigen receptor T cells","volume":"22","author":"\u0160tach","year":"2020","journal-title":"Cytotherapy"},{"key":"10.1016\/j.ccell.2025.11.009_bib41","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1016\/j.celrep.2017.11.063","article-title":"CAR T Cells Releasing IL-18 Convert to T-Bethigh FoxO1low Effectors that Exhibit Augmented Activity against Advanced Solid Tumors","volume":"21","author":"Chmielewski","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.ccell.2025.11.009_bib42","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1158\/2326-6066.CIR-21-0536","article-title":"Superkine IL-2 and IL-33 Armored CAR T Cells Reshape the Tumor Microenvironment and Reduce Growth of Multiple Solid Tumors","volume":"10","author":"Brog","year":"2022","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ccell.2025.11.009_bib43","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/imr.12125","article-title":"Of CARs and TRUCKs: Chimeric antigen receptor (CAR) T cells engineered with an inducible cytokine to modulate the tumor stroma","volume":"257","author":"Chmielewski","year":"2014","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ccell.2025.11.009_bib44","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1517\/14712598.2015.1046430","article-title":"TRUCKs: the fourth generation of CARs","volume":"15","author":"Chmielewski","year":"2015","journal-title":"Expet Opin. Biol. Ther."},{"key":"10.1016\/j.ccell.2025.11.009_bib45","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abe7378","article-title":"SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma","volume":"13","author":"Choe","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ccell.2025.11.009_bib46","doi-asserted-by":"crossref","DOI":"10.1126\/science.aba1624","article-title":"Synthetic cytokine circuits that drive T cells into immune-excluded tumors","volume":"378","author":"Allen","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.ccell.2025.11.009_bib47","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1158\/2159-8290.CD-23-0101","article-title":"Programming CAR T Cell Tumor Recognition: Tuned Antigen Sensing and Logic Gating","volume":"13","author":"Hamieh","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2025.11.009_bib48","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/sj.gt.3301124","article-title":"Development of a hypoxia-responsive vector for tumor-specific gene therapy","volume":"7","author":"Shibata","year":"2000","journal-title":"Gene Ther."},{"key":"10.1016\/j.ccell.2025.11.009_bib49","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1016\/j.ymthe.2024.06.017","article-title":"Building a novel TRUCK by harnessing the endogenous IFN-gamma promoter for cytokine expression","volume":"32","author":"Ma","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ccell.2025.11.009_bib50","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/j.ymthe.2023.04.021","article-title":"A chemically inducible IL-2 receptor signaling complex allows for effective in vitro and in vivo selection of engineered CD4+ T cells","volume":"31","author":"Cook","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ccell.2025.11.009_bib51","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.celrep.2019.06.066","article-title":"Single-Cell Analysis Suggests that Ongoing Affinity Maturation Drives the Emergence of Pemphigus Vulgaris Autoimmune Disease","volume":"28","author":"Cho","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.ccell.2025.11.009_bib52","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1016\/j.ymthe.2024.08.018","article-title":"TALEN-edited allogeneic inducible dual CAR T cells enable effective targeting of solid tumors while mitigating off-tumor toxicity","volume":"32","author":"Dharani","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ccell.2025.11.009_bib53","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13148-023-01482-0","article-title":"Epigenetic reactivation of tumor suppressor genes with CRISPRa technologies as precision therapy for hepatocellular carcinoma","volume":"15","author":"Sgro","year":"2023","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.ccell.2025.11.009_bib54","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1038\/s41592-025-02808-x","article-title":"Deep generative modeling of sample-level heterogeneity in single-cell genomics","volume":"22","author":"Boyeau","year":"2025","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ccell.2025.11.009_bib55","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41587-021-01206-w","article-title":"A Python library for probabilistic analysis of single-cell omics data","volume":"40","author":"Gayoso","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ccell.2025.11.009_bib56","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.it.2025.03.001","article-title":"IL-1\u03b2+ macrophages and the control of pathogenic inflammation in cancer","volume":"46","author":"Caronni","year":"2025","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ccell.2025.11.009_bib57","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41586-023-06708-y","article-title":"Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes","volume":"623","author":"Zhang","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.11.009_bib58","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1182\/blood-2011-12-400044","article-title":"Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning","volume":"119","author":"Pegram","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2025.11.009_bib59","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41591-018-0010-1","article-title":"Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia","volume":"24","author":"Fraietta","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2025.11.009_bib60","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.ccell.2025.03.021","article-title":"ZEB2 is a master switch controlling the tumor-associated macrophage program","volume":"43","author":"Sheban","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2025.11.009_bib61","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s41586-019-0985-x","article-title":"NR4A transcription factors limit CAR T cell function in solid tumours","volume":"567","author":"Chen","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.11.009_bib62","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41590-021-00964-8","article-title":"BATF and IRF4 cooperate to counter exhaustion in tumor-infiltrating CAR T cells","volume":"22","author":"Seo","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ccell.2025.11.009_bib63","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1084\/jem.20082731","article-title":"Transcriptional complexes formed by NFAT dimers regulate the induction of T cell tolerance","volume":"206","author":"Soto-Nieves","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ccell.2025.11.009_bib64","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jim.2016.01.007","article-title":"Assessment of costimulation and coinhibition in a triple parameter T cell reporter line: Simultaneous measurement of NF-\u03baB, NFAT and AP-1","volume":"430","author":"Jutz","year":"2016","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ccell.2025.11.009_bib65","doi-asserted-by":"crossref","first-page":"9959","DOI":"10.1073\/pnas.1820604116","article-title":"Targeting the NFAT:AP-1 transcriptional complex on DNA with a small-molecule inhibitor","volume":"116","author":"Mognol","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2025.11.009_bib66","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3389\/fimmu.2020.00633","article-title":"Multiplex T Cell Stimulation Assay Utilizing a T Cell Activation Reporter-Based Detection System","volume":"11","author":"Mann","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ccell.2025.11.009_bib67","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/nature08473","article-title":"The role of DNA shape in protein\u2013DNA recognition","volume":"461","author":"Rohs","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.11.009_bib68","doi-asserted-by":"crossref","first-page":"11883","DOI":"10.1093\/nar\/gky1057","article-title":"Flexibility and structure of flanking DNA impact transcription factor affinity for its core motif","volume":"46","author":"Yella","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ccell.2025.11.009_bib69","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.celrep.2013.03.014","article-title":"Genomic Regions Flanking E-Box Binding Sites Influence DNA Binding Specificity of bHLH Transcription Factors through DNA Shape","volume":"3","author":"Gord\u00e2n","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.ccell.2025.11.009_bib70","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1084\/jem.20171529","article-title":"Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism","volume":"215","author":"Song","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ccell.2025.11.009_bib71","doi-asserted-by":"crossref","DOI":"10.1093\/nsr\/nwae018","article-title":"Lymph node-biomimetic scaffold boosts CAR-T therapy against solid tumor","volume":"11","author":"Liao","year":"2024","journal-title":"Natl. Sci. Rev."},{"key":"10.1016\/j.ccell.2025.11.009_bib72","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1016\/j.ymthe.2020.09.015","article-title":"CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?","volume":"28","author":"Wagner","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ccell.2025.11.009_bib73","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/j.ymthe.2019.07.015","article-title":"Phase I Study of Lentiviral-Transduced Chimeric Antigen Receptor-Modified T Cells Recognizing Mesothelin in Advanced Solid Cancers","volume":"27","author":"Haas","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ccell.2025.11.009_bib74","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa0984","article-title":"A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma","volume":"9","author":"O\u2019Rourke","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ccell.2025.11.009_bib75","doi-asserted-by":"crossref","first-page":"5983","DOI":"10.3390\/cancers14235983","article-title":"Efficacy, Safety, and Challenges of CAR T-Cells in the Treatment of Solid Tumors","volume":"14","author":"Chen","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ccell.2025.11.009_bib76","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.cell.2020.06.032","article-title":"Coupled scRNA-Seq and Intracellular Protein Activity Reveal an Immunosuppressive Role of TREM2 in Cancer","volume":"182","author":"Katzenelenbogen","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.11.009_bib77","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nrd.2018.169","article-title":"Targeting macrophages: therapeutic approaches in cancer","volume":"17","author":"Cassetta","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ccell.2025.11.009_bib94","doi-asserted-by":"crossref","first-page":"4737","DOI":"10.1038\/s41467-023-40115-1","article-title":"Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targeting","volume":"14","author":"Lee","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2025.11.009_bib95","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ygyno.2020.06.089","article-title":"A phase I clinical trial of autologous chimeric antigen receptor (CAR) T cells genetically engineered to secrete IL-12 and to target the MUC16ecto antigen in patients (pts) with MUC16ecto+ recurrent high-grade serous ovarian cancer (HGSOC)","volume":"159","author":"O\u2019Cearbhaill","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ccell.2025.11.009_bib96","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003633","article-title":"Cell membrane-anchored and tumor-targeted IL-12 (attIL12)-T cell therapy for eliminating large and heterogeneous solid tumors","volume":"10","author":"Hu","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ccell.2025.11.009_bib78","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1158\/2326-6066.CIR-22-0374","article-title":"EBV-Upregulated B7-H3 Inhibits NK cell\u2013Mediated Antitumor Function and Contributes to Nasopharyngeal Carcinoma Progression","volume":"11","author":"Chen","year":"2023","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ccell.2025.11.009_bib79","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.3390\/cancers12071760","article-title":"MHC Class I Downregulation in Cancer: Underlying Mechanisms and Potential Targets for Cancer Immunotherapy","volume":"12","author":"Cornel","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ccell.2025.11.009_bib80","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41577-022-00732-1","article-title":"Roles of natural killer cells in immunity to cancer, and applications to immunotherapy","volume":"23","author":"Wolf","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ccell.2025.11.009_bib90","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1186\/gb-2008-9-9-r137","article-title":"Model-based analysis of ChIP-Seq (MACS)","volume":"9","author":"Zhang","year":"2008","journal-title":"Genome Biol."},{"key":"10.1016\/j.ccell.2025.11.009_bib82","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13059-017-1382-0","article-title":"SCANPY: large-scale single-cell gene expression data analysis","volume":"19","author":"Wolf","year":"2018","journal-title":"Genome Biol."},{"key":"10.1016\/j.ccell.2025.11.009_bib83","doi-asserted-by":"crossref","first-page":"W191","DOI":"10.1093\/nar\/gkz369","article-title":"g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update)","volume":"47","author":"Raudvere","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ccell.2025.11.009_bib84","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cels.2018.11.005","article-title":"Scrublet: Computational Identification of Cell Doublets in Single-Cell Transcriptomic Data","volume":"8","author":"Wolock","year":"2019","journal-title":"Cell Syst."},{"key":"10.1016\/j.ccell.2025.11.009_bib85","author":"Tickle"},{"key":"10.1016\/j.ccell.2025.11.009_bib86","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14806\/ej.17.1.200","article-title":"Cutadapt removes adapter sequences from high-throughput sequencing reads","volume":"17","author":"Martin","year":"2011","journal-title":"EMBnet. j."},{"key":"10.1016\/j.ccell.2025.11.009_bib87","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ccell.2025.11.009_bib88","doi-asserted-by":"crossref","DOI":"10.1093\/gigascience\/giab008","article-title":"Twelve years of SAMtools and BCFtools","volume":"10","author":"Danecek","year":"2021","journal-title":"GigaScience"},{"key":"10.1016\/j.ccell.2025.11.009_bib89","author":"Institute"},{"key":"10.1016\/j.ccell.2025.11.009_bib91","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btad547","article-title":"PyDESeq2: a python package for bulk RNA-seq differential expression analysis","volume":"39","author":"Muzellec","year":"2023","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ccell.2025.11.009_bib92","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","article-title":"Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell Identities","volume":"38","author":"Heinz","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ccell.2025.11.009_bib81","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1126\/science.1247651","article-title":"Massively parallel single-cell RNA-seq for marker-free decomposition of tissues into cell types","volume":"343","author":"Jaitin","year":"2014","journal-title":"Science"}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610825005021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610825005021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:25:59Z","timestamp":1791347159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610825005021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":95,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1535610825005021"],"URL":"https:\/\/doi.org\/10.1016\/j.ccell.2025.11.009","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor-antigen-independent targeting of solid tumors by armored macrophage-directed anti-TREM2 CAR T cells","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2025.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}